Medicine and Dentistry
Kidney Graft
95%
Spironolactone
76%
Fibrosis
53%
Calcineurin Inhibitor
50%
Nephrotoxicity
47%
Biological Marker
47%
Placebo
46%
Mineralocorticoid Receptor
37%
Kidney Allograft
35%
Idiopathic Pulmonary Fibrosis
31%
Kidney Function
29%
Clinical Trial
29%
Kidney Transplantation
26%
Graft Survival
25%
Vasculitis
23%
Controlled Clinical Trial
23%
Edema
23%
Nephrotic Syndrome
23%
Endothelial Function
23%
Patient with Nephrotic Syndrome
23%
Amiloride
23%
Epithelial Sodium Channel
23%
Proteomics
23%
Proteinuria
19%
Mineralocorticoid Antagonist
16%
Endothelial Dysfunction
16%
Aldosterone
16%
Allograft
13%
Biopsy Technique
13%
Kidney Fibrosis
13%
Glomerular Filtration Rate
11%
Randomized Clinical Trial
11%
Mineralocorticoid
11%
Cardiovascular System
8%
Blood Pressure
8%
Arginine
7%
Immune Response
7%
Cytoskeleton
7%
Nitrite
7%
N(g),n(g) Dimethylarginine
7%
Human Study
5%
Edetic Acid
5%
Acute Graft Rejection
5%
Pharmacology, Toxicology and Pharmaceutical Science
Spironolactone
100%
Mineralocorticoid Receptor
61%
Placebo
51%
Calcineurin Inhibitor
50%
Nephrotoxicity
47%
Fibrosis
35%
Clinical Trial
29%
Amiloride
27%
Vasculitis
23%
Controlled Clinical Trial
23%
Polyuria
23%
Nephrotic Syndrome
23%
Biological Marker
23%
Interleukin 17
23%
Edema
23%
Fibrosing Alveolitis
23%
Nephrogenic Diabetes Insipidus
23%
Aldosterone
21%
Epithelial Sodium Channel
19%
Mineralocorticoid Antagonist
19%
Proteinuria
19%
Creatinine
16%
Endothelial Dysfunction
16%
Cytokine
16%
Randomized Clinical Trial
14%
Aquaporin 2
13%
Mineralocorticoid
11%
Inflammation
11%
Trefoil Factor 3
10%
Vasopressin V2 Receptor
10%
Arginine
7%
Nitrite
7%
6 N,n' Dimethylarginine
7%
N(g),n(g) Dimethylarginine
7%
Cell Adhesion Proteins
7%
Argipressin
6%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
6%
Dipeptidyl Carboxypeptidase Inhibitor
6%
Ethylenediaminetetraacetic Acid
5%
Aldosterone Antagonist
5%
Acute Graft Rejection
5%
Human Study
5%
